More on LH
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $323.75 |
|
|||
| Open | $320.20 | ||||
| 52 Wk High | $141.32 | ||||
| 52 Wk Low | $97.79 | ||||
| Day High | $331.71 | ||||
| Day Low | $314.78 | ||||
| P/E | 52.79 | ||||
| EPS | $6.25 | ||||
| Volume | 937,510 | ||||
- Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential
- Form 8-K LABCORP HOLDINGS INC. For: Oct 20
- Labcorp (LH) Declares $0.72 Quarterly Dividend; 0.9% Yield
- Labcorp Declares Quarterly Dividend
- Myriad Genetics stock surges on $210M prenatal unit sale
- Myriad Genetics to sell prenatal testing unit to Labcorp for $210M
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
- Opko Health stock soars on $722M BioReference asset sale
- Labcorp to buy BioReference Health assets from OPKO for $722M
- Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Entities mentioned with LH
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Dividend | View Related Stories »
- Show More...
